Showing results (11-20 of 36) with videos related to
Sort By:
Pageof 4
Anticancer Research|September 12, 2013
Docetaxel in the treatment of non-small cell lung cancer (NSCLC) -- an observational study focusing on symptom improvementAndreas Pircher, Ines Kristin Wasle, Michael Mian, et al.Cancers|November 17, 2019
Tumor Mutational Burden and Efficacy of Immune Checkpoint Inhibitors: A Systematic Review and Meta-AnalysisJong Yeob Kim, Andreas Kronbichler, Michael Eisenhut, et al.Annals of Hematology|November 13, 2014
Non-pegylated liposomal doxorubicin in lymphoma: patterns of toxicity and outcome in a large observational trialInes Wasle, Gabriele Gamerith, Florian Kocher, et al.Liver International : Official Journal of the International Association for the Study of the Liver|June 8, 2011
AKR1B10 expression is associated with less aggressive hepatocellular carcinoma: a clinicopathological study of 168 casesKlaus J Schmitz, Georgios C Sotiropoulos, Hideo A Baba, et al.Immunobiology|February 16, 2016
Infiltration of lymphocyte subpopulations into cancer microtissues as a tool for the exploration of immunomodulatory agents and biomarkersStefan Koeck, Marit Zwierzina, Julia M Huber, et al.Journal of Clinical Medicine|January 26, 2020
Statin and Cancer Mortality and Survival: An Umbrella Systematic Review and Meta-AnalysisGwang Hun Jeong, Keum Hwa Lee, Jong Yeob Kim, et al.Cancers|October 27, 2022
Molecular Characteristics of Radon Associated Lung Cancer Highlights MET AlterationsGabriele Gamerith, Marcel Kloppenburg, Finn Mildner, et al.Cancers|November 17, 2019
Efficacy of Cancer Immunotherapy: An Umbrella Review of Meta-analyses of Randomized Controlled TrialsJong Yeob Kim, Keum Hwa Lee, Michael Eisenhut, et al.Oncology Letters|November 17, 2017
Aviscumine, a recombinant ribosomal inhibitor, increases the antitumor activity of natural killer cellsGabriele Gamerith, Arno Amann, Bettina Schenk, et al.Scientific Reports|June 9, 2017
Development of a 3D angiogenesis model to study tumour - endothelial cell interactions and the effects of anti-angiogenic drugsArno Amann, Marit Zwierzina, Stefan Koeck, et al.Pageof 4